A Study to Assess the Potential for Airway Sensitivity Reactions With Propellants HFA-152a (Test) and HFA-134a (Reference) Administered Via Pressurized Inhalers in Adults With Mild Asthma

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 11, 2025

Primary Completion Date

June 4, 2025

Study Completion Date

June 4, 2025

Conditions

Asthma

Interventions

DRUG

HFA-152A propellant

HFA-152A propellant is administered via oral inhalation

DRUG

HFA-134A propellant

HFA-134A propellant is administered via oral inhalation

Trial Locations (3)

GSK Investigational Site, Huntersville

GSK Investigational Site, San Antonio

GSK Investigational Site, Marlton